MENU
+Compare
LEXX
Stock ticker: NASDAQ
AS OF
Apr 2, 04:59 PM (EDT)
Price
$1.69
Change
+$0.05 (+3.05%)
Capitalization
29.31M

LEXX Lexaria Bioscience Corp Forecast, Technical & Fundamental Analysis

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery... Show more

LEXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for LEXX with price predictions
Apr 01, 2025

LEXX's RSI Indicator ascending out of oversold territory

The RSI Oscillator for LEXX moved out of oversold territory on March 05, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 30 similar instances when the indicator left oversold territory. In of the 30 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on March 17, 2025. You may want to consider a long position or call options on LEXX as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LEXX just turned positive on March 07, 2025. Looking at past instances where LEXX's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

LEXX moved above its 50-day moving average on March 21, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for LEXX crossed bullishly above the 50-day moving average on March 28, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where LEXX advanced for three days, in of 255 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 138 cases where LEXX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 46 cases where LEXX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LEXX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LEXX broke above its upper Bollinger Band on March 20, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.999) is normal, around the industry mean (13.458). P/E Ratio (0.000) is within average values for comparable stocks, (64.587). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.867). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (48.077) is also within normal values, averaging (251.391).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LEXX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LEXX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
LEXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

LEXX is expected to report earnings to rise 6.25% to -17 cents per share on April 15

Lexaria Bioscience Corp LEXX Stock Earnings Reports
Q1'25
Est.
$-0.17
Q4'24
Missed
by $0.08
Q3'24
Missed
by $0.02
Q2'24
Est.
$-0.13
Q1'24
Beat
by $0.02
The last earnings report on January 15 showed earnings per share of -15 cents, missing the estimate of -7 cents. With 34.17K shares outstanding, the current market capitalization sits at 29.31M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
740 McCurdy Road
Phone
+1 250 765-6424
Employees
5
Web
https://www.lexariabioscience.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABEV2.340.01
+0.43%
Ambev SA
SBT4.84N/A
N/A
Sterling Bancorp
IHS5.21-0.01
-0.19%
IHS Holding Limited
KTOS29.30-0.39
-1.31%
Kratos Defense & Security Solutions
CLNN2.58-0.50
-16.23%
Clene Inc.

LEXX and Stocks

Correlation & Price change

A.I.dvisor tells us that LEXX and MIST have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LEXX and MIST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LEXX
1D Price
Change %
LEXX100%
-4.09%
MIST - LEXX
28%
Poorly correlated
-5.01%
RGNX - LEXX
27%
Poorly correlated
-5.45%
BTAI - LEXX
27%
Poorly correlated
-5.42%
VXRT - LEXX
27%
Poorly correlated
-8.48%
EPRX - LEXX
27%
Poorly correlated
-0.02%
More